A simplified nomogram to assess risk of bladder cancer in patients with a new diagnosis of microscopic hematuria
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 38 (4) , 240-246
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Association of American Medical Colleges
This publication has 19 references indexed in Scilit:
- Hematuria as a Marker of Occult Urinary Tract Cancer: Advice for High-Value Care From the American College of PhysiciansAnnals of Internal Medicine, 2016
- Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancerBJU International, 2015
- Enabling a Learning Health System through a Unified Enterprise Data Warehouse: The Experience of the Northwestern University Clinical and Translational Sciences (NUCATS) InstituteClinical and Translational Science, 2015
- Evaluating Hematuria: Impact of Guideline Adherence on Urologic Cancer DiagnosisThe American Journal of Medicine, 2014
- Stratifying Risk of Urinary Tract Malignant Tumors in Patients With Asymptomatic Microscopic HematuriaMayo Clinic Proceedings, 2013
- Epidemiology and Risk Factors of Urothelial Bladder CancerEuropean Urology, 2013
- Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA GuidelineJournal of Urology, 2012
- Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancerWorld Journal of Urology, 2012
- Association of Hematuria on Microscopic Urinalysis and Risk of Urinary Tract CancerJournal of Urology, 2011
- Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based surveyUrologic Oncology: Seminars and Original Investigations, 2010